Anticancer therapies enhanced by Small Radiolabelled Necrosis-Avid Compounds(sRaLNAC): a Proof-of-Principle investigation for supporting a new patent application.
Priming lung cancer cells and the tumor microenvironment for an anticancer immune response with Auranofin.
Nieuwe inzichten in Protein Kinase D structuur en regeling ten dienste van de ontwikkeling van innovatieve anti-cancer kinase inhibitors.
Oligonucleotides for medical applications – OLIGOMED EU H2020 MSC ETN - Project 956070 - Furan and porphyrin containing crosslinking ligands for covalent stabilisation of G-quadruplexes as cell-permeable anti-cancer aptamers
Re-engineering vesicle sorting signals of the mannose-6-phosphate receptor in an mRNA-vaccine approach to enable full anti-cancer T-cell engagement
Adherence to oral anticancer drugs (OAD) in patients (pts) with metastatic renal cancer (mRCC): First results of the prospective observational multicenter IPSOC study (Investigating Patient Satisfaction with Oral Anti-cancer Treatment).
Adherence to oral anticancer drugs: influencing factors and underlying processes, usual care and healthcare professionals' perceptions of adherence to oral anticancer drugs
A qualitative evaluation of the process of creating and implementing an interprofessional care pathway for patients treated with oral anticancer drugs
Patient-centered care coordination, education and counseling of patients treated with oral anticancer drugs : an importance-performance analysis